Ajanta Pharma Q3 Results
- BSE: 532331
- NSE: AJANTPHARM
- ISIN: INE031B01049
- Sector: Biotechnology & Drugs
BSE
2,644.30
16.20 (0.62%)
16.20 (0.62%)Volume5.91 K
Updated: Mon 14 Jul, 2025 | 15:16:12
NSE
2,640.7014.20 (0.54%)
14.20 (0.54%)Volume4.30 L
Updated: Mon 14 Jul, 2025 | 15:02:36
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Ajanta Pharma Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 24 | Sep 24 | QoQ Comp | Dec 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 861.27 | 884.21 | -2.59% | 861.27 | N/A |
| Depreciation/ Amortization | 35.97 | 34.39 | 4.59% | 35.97 | N/A |
| Operating Income | 284.86 | 302.43 | -5.81% | 284.86 | N/A |
| Net Income | 232.88 | 216.48 | 7.58% | 232.88 | N/A |
| Other Operating Expenses Total | 302.32 | 327.18 | -7.60% | 302.32 | N/A |
| Net Income Before Taxes | 307.39 | 290.24 | 5.91% | 307.39 | N/A |
| Total Revenue | 1,146.13 | 1,186.64 | -3.41% | 1,146.13 | N/A |
| Selling/ General/ Admin Expenses Total | 265.17 | 260.96 | 1.61% | 265.17 | N/A |
| Diluted Normalized EPS | 18.59 | 17.26 | 7.71% | 18.59 | N/A |